Cited by 320Wnt/β-catenin signaling in development and cancerGenetics, Aging, and Longevity in Model OrganismsComplement system in diseases

Complement C1q Activates Canonical Wnt Signaling and Promotes Aging-Related Phenotypes

Open access
Naito, Atsuhiko T., Sumida, Tomokazu, Nomura, Seitaro, Liu, Mei-Lan, Higo, Tomoaki, Nakagawa, Akito, Okada, Katsuki, Sakai, Taku +17 more·2012·Cell

Abstract

Wnt signaling plays critical roles in development of various organs and pathogenesis of many diseases, and augmented Wnt signaling has recently been implicated in mammalian aging and aging-related phenotypes. We here report that complement C1q activates canonical Wnt signaling and promotes aging-associated decline in tissue regeneration. Serum C1q concentration is increased with aging, and Wnt signaling activity is augmented during aging in the serum and in multiple tissues of wild-type mice, but not in those of C1qa-deficient mice. C1q activates canonical Wnt signaling by binding to Frizzled receptors and subsequently inducing C1s-dependent cleavage of the ectodomain of Wnt coreceptor low-density lipoprotein receptor-related protein 6. Skeletal muscle regeneration in young mice is inhibited by exogenous C1q treatment, whereas aging-associated impairment of muscle regeneration is restored by C1s inhibition or C1qa gene disruption. Our findings therefore suggest the unexpected role of complement C1q in Wnt signal transduction and modulation of mammalian aging.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2012.03.047

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The benefits of GPLD1 and other exerkines on brain structure and function may relate to peripheral effects such as complement signalling or coagulation.

    “Hence, the benefit of GPLD1 (REF.148) and other exerkines on brain structure and function might relate to its peripheral effects, such as the complement signalling cascade149,158, or coagulation159.”

    From Exerkines in health, resilience and disease (2022) · cites this paper as [158]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Naito, A. T., Sumida, T., Nomura, S., Liu, M.-L., Higo, T., Nakagawa, A., Okada, K., Sakai, T., Hashimoto, A., Hara, Y., Shimizu, I., Zhu, W., Toko, H., Katada, A., Akazawa, H., Oka, T., Lee, J.-K., Minamino, T., Nagai, T., Walsh, K., Kikuchi, A., Matsumoto, M., Botto, M., Shiojima, I., & Komuro, I.
Affiliations
  • Japan Science and Technology Agency (JP)
  • Chiba University (JP)
  • The University of Osaka (JP)
  • Boston University (US)
  • Hokkaido University (JP)
  • Imperial College London (GB)
Corresponding author
Komuro, Issei
Venue
Cell
Publisher
Elsevier BV
Published
2012-06
Volume
149
Issue
6
Pages
1298-1313
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2160766576
Cited by
320
References
46
Citations by year
2026: 19 · 2025: 20 · 2024: 16 · 2023: 24 · 2022: 32 · 2021: 23 · 2020: 29 · 2019: 23 · 2018: 24 · 2017: 25 · 2016: 22 · 2015: 23 · 2014: 16 · 2013: 15 · 2012: 9
FWCI
8.11
Type
journal article
Language
en
Update notices
erratum (2012-08-03)
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Japan Prize Foundation
  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Science and Technology Agency
  • Japan Foundation for Applied Enzymology
  • Japan Society for the Promotion of Science
  • Ministry of Health, Labour and Welfare
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
Keywords
C1q, Wnt/β-catenin signaling, aging, tissue regeneration, Frizzled receptors, skeletal muscle regeneration
MeSH terms
Aging, Animals, Complement C1s, Humans, Complement C1q, Serum, Mice, Wnt Signaling Pathway, Low Density Lipoprotein Receptor-Related Protein-6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review